Transcript PPT - American Academy of Pediatrics

TM
TM
Prepared for your next patient.
2011 Immunization
Recommendations
H. Cody Meissner, M.D.
Professor of Pediatrics
Tufts University School of Medicine
Boston Floating Hospital for Children
Tufts Medical Center
TM
Disclaimers
 Statements and opinions expressed are those of the author and not
necessarily those of the American Academy of Pediatrics.
 Mead Johnson sponsors programs such as this to give healthcare
professionals access to scientific and educational information provided by
experts. The presenter has complete and independent control over the
planning and content of the presentation, and is not receiving any
compensation from Mead Johnson for this presentation. The presenter’s
comments and opinions are not necessarily those of Mead Johnson. In the
event that the presentation contains statements about uses of drugs that
are not within the drugs' approved indications, Mead Johnson does not
promote the use of any drug for indications outside the FDA-approved
product label.
TM
Considerations which Influence the Age
at which a Vaccine is Recommended






Age-specific risk of a disease
Immune response to vaccine
Interference by maternal antibody
Waning immunity
Programmatic issues
“Crowding of the schedule”
TM
Use of Tetanus and Diphtheria and
Acellular Pertussis (Tdap) Vaccines
 Removal of interval between Tdap and tetanus
or diphtheria toxoid containing vaccine
 Use of Tdap in certain adults ≥65 years of age
 Use of Tdap in under-vaccinated children 7
through 10 years of age
TM
Changes to the Meningococcal Conjugate
Vaccine Schedule
 Booster dose
 Routine vaccination at 11 through 12 years with
booster dose at 16 through 21 years
 If first dose at 13 through 15 years, booster dose
preferred at 16 through 18 years
 Persons 2 through 54 years at increased risk
of meningococcal disease should receive a 2
dose primary series (2 months apart), then
booster dose every 5 years
TM
13 Valent Pneumococcal Conjugate Vaccine
(PCV13) Recommendations
 PCV13 recommended for all children 2 through 59
months
 A 4 dose series at 2,4,6 and 12 through 15 months
 Complete series with PCV13 if begun with PCV7
 Supplemental dose of PCV13 for children 14-59
months who completed PCV7 schedule
 Supplemental dose of PCV13 for children 60
through 71 months after PCV7 schedule if increased
risk
TM
2010-2011 Influenza Vaccine Recommendations
 Routine vaccination of all persons ≥6 months
with emphasis on high risk groups
 For children 6 months through 8 years
 If vaccinated for 1st time, 2 doses needed
 If only 1 dose of seasonal vaccine in 2009-2010 and
none in previous years, then 2 doses needed
 If no doses of novel H1N1 last year, then 2 doses
needed
 Healthy, non-pregnant persons 2 through 49
years can receive TIV or LAIV
TM
HPV Vaccine Recommendations
 Quadrivalent HPV vaccine (HPV4) or
bivalent (HPV2) vaccine recommended
for prevention of cervical precancers
and cancers in females
 HPV4 recommended for prevention of
precancers, cancers and genital warts in
females
 HPV4 may be administered to males to
reduce risk of genital warts
TM
Haemophilus influenzae type b Vaccine
 For people ≥5 years at increased risk of
infection, one dose should be
considered




Sickle cell disease
Leukemia
HIV infection
Lack a spleen
TM
Hepatitis B Vaccine
 For infants who do not receive a birth
dose:
 Administer 3 doses of HepB on a schedule
of 0, 1 and 6 months
 The final (3rd or 4th) dose in the HepB series
should be administered no earlier than age
24 weeks
TM
For more information….

On this topic and a host of other topics, visit
www.pediatriccareonline.org. Pediatric Care Online is a convenient electronic
resource for immediate expert help with virtually
every pediatric clinical information need. Must-have resources are included in a
comprehensive reference library and time-saving clinical tools. .
• Haven't activated your Pediatric Care Online trial subscription yet? It's
quick and easy: simply follow the steps on the back of the card you
received from your Mead Johnson representative.
• Haven't received your free trial card? Contact your Mead Johnson
representative or call 888/363-2362 today.